Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Dolby Laboratories Inc Cl A / Equity Bottom-Up

<ul><li>Dolby Laboratories delivered a mixed fiscal third quarter 2024 performance, as outlined in their recent earnings call.</li><li>The company registered revenues slightly above the midpoint of their previously projected range, with earnings surpassing the higher end.</li><li>However, Dolby Laboratories now expects a full-year revenue decline of about 1% to 2%, positioning at the lower end of their initial annual projections.</li></ul>

Dolby Laboratories delivered a mixed fiscal third quarter 2024 performance, as outlined in their recent earnings call.The company registered revenues slightly above the midpoint of their previously projected range, with earnings surpassing the higher end.However, Dolby Laboratories now expects a full-year revenue decline of about 1% to 2%, positioning at the lower end of their initial annual projections.

Dolby Laboratories Inc.: Acquisition of THEO Technologies to Revolutionize Real-Time Video Streaming & Other Key Developments! - Major Drivers

<ul><li>Dolby Laboratories, Inc., a leader in immersive entertainment technologies, posted its Q2 2024 results, providing significant insights into its performance and future outlook.</li><li>The report highlighted that the revenues were on par with their expectations, while the earnings exceeded the forecasted figures.</li><li>However, the full-year guidance remained unchanged.</li></ul>

Dolby Laboratories, Inc., a leader in immersive entertainment technologies, posted its Q2 2024 results, providing significant insights into its performance and future outlook.The report highlighted that the revenues were on par with their expectations, while the earnings exceeded the forecasted figures.However, the full-year guidance remained unchanged.

Dolby Laboratories Inc.: Will The Increased Demand for Dolby Atmos and Dolby Vision Technology Last? - Major Drivers

<ul><li>Dolby Laboratories saw revenue for the quarter in line with expectations, and earnings better than anticipated.</li><li>This positive update on earnings should please investors and cement confidence in Dolby's financial stability.</li><li>The company highlighted three key points: the macro-economic environment, the company’s business and product momentum, and some closing thoughts.</li></ul>

Dolby Laboratories saw revenue for the quarter in line with expectations, and earnings better than anticipated.This positive update on earnings should please investors and cement confidence in Dolby's financial stability.The company highlighted three key points: the macro-economic environment, the company’s business and product momentum, and some closing thoughts.

Dolby Laboratories: Growth in Dolby Atmos

<ul><li>Dolby Laboratories had an intriguing fourth quarter for the 2023 fiscal year, highlighted with both positive and negative factors that play into its future investment potential.</li><li>The company saw solid growth in its Dolby Atmos, Dolby Vision, and imaging patents, building a strong foundation for them to leverage long-term growth.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

Dolby Laboratories had an intriguing fourth quarter for the 2023 fiscal year, highlighted with both positive and negative factors that play into its future investment potential.The company saw solid growth in its Dolby Atmos, Dolby Vision, and imaging patents, building a strong foundation for them to leverage long-term growth.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

Dolby Laboratories Inc: Initiation of Coverage – What Are The 4 Biggest Factors Shaping Their Future? - Financial Forecasts

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<p style="text-align: justify;">In our November Strategy book we summarize the basis for our bullish outlook, discuss the deservedly hot topic of value vs. growth. and highlight actionable opportunities within our <span>Manufacturing, Transportation, M</span>aterials, Technology, &amp; Consumer Discretionary Sectors.</p>

In our November Strategy book we summarize the basis for our bullish outlook, discuss the deservedly hot topic of value vs. growth. and highlight actionable opportunities within our Manufacturing, Transportation, Materials, Technology, &amp; Consumer Discretionary Sectors.

United States

Dolby Laboratories Inc. develops audio signal processing systems for the motion picture, broadcasting, and music recording industries, as well as the consumer market.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Dolby Laboratories Inc Cl A (DLB US)

Dolby Laboratories Inc.: Acquisition of THEO Technologies to Revolutionize Real-Time Video Streaming & Other Key Developments! - Major Drivers

Dolby Laboratories delivered a mixed fiscal third quarter 2024 performance, as outlined in their recent earnings call. The company registered...

Baptista Research

Dolby Laboratories Inc.: Will The Increased Demand for Dolby Atmos and Dolby Vision Technology Last? - Major Drivers

Dolby Laboratories, Inc., a leader in immersive entertainment technologies, posted its Q2 2024 results, providing significant insights into its...

Baptista Research

Dolby Laboratories: Growth in Dolby Atmos

Dolby Laboratories saw revenue for the quarter in line with expectations, and earnings better than anticipated. This positive update on earnings...

Baptista Research

Dolby Laboratories Inc: Initiation of Coverage – What Are The 4 Biggest Factors Shaping Their Future? - Financial Forecasts

Dolby Laboratories had an intriguing fourth quarter for the 2023 fiscal year, highlighted with both positive and negative factors that play into...

Baptista Research

U.S. Equity Strategy: Remain Bullish

In our November Strategy book we summarize the basis for our bullish outlook, discuss the deservedly hot topic of value vs. growth. and highlight...

Vermilion Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)